welcome
USA Today

USA Today

Health

Health

Feds recommend pausing vaccine for mosquito-borne disease chikungunya in people over 60

USA Today
Summary
Nutrition label

90% Informative

17 serious adverse events, including two that resulted in death, have been reported in recipients of the vaccine Ixchiq over the age of 60 .

Six of the events occurred in the United States .

The vaccine's maker, Valneva , said in a statement that it is "upholding the highest safety standards".